Guides·8 min read

21 CFR Part 11 and Material Certificates: Compliance Requirements Explained

Quick Answer

Quick Answer

21 CFR Part 11 requires that electronic records used in FDA-regulated manufacturing — including material test certificates — meet specific standards for authenticity, integrity, and confidentiality. For material certificates, this means compliant electronic signatures, audit trails on every record modification, access controls, and validated systems. Non-compliance creates regulatory exposure during FDA inspections.

If your organization fabricates equipment for pharmaceutical or biotech manufacturing — pressure vessels, bioreactors, piping systems, process equipment — your customers operate under FDA oversight. That oversight extends to the documentation practices of their equipment suppliers, particularly when material records are incorporated into the batch record or equipment qualification package.

Understanding where 21 CFR Part 11 applies to your material certificate management system is not optional. It affects how you capture, store, approve, and transmit every quality document that enters an FDA-regulated supply chain.


What Is 21 CFR Part 11?

Title 21 of the Code of Federal Regulations, Part 11, is the FDA regulation that establishes the conditions under which electronic records and electronic signatures are considered equivalent to paper records and handwritten signatures.

It was introduced in 1997 to accommodate the transition from paper-based quality systems to electronic systems — but it applies strict requirements to ensure that electronic records cannot be tampered with, falsified, or misattributed.

21 CFR Part 11 applies when:

  • The record is required by other FDA regulations (e.g., cGMP under 21 CFR Parts 210/211)
  • The organization chooses to use electronic records in lieu of paper

For material certificate management in pharmaceutical equipment fabrication, the regulation becomes relevant when certificates are retained and signed electronically as part of the regulated manufacturer's documentation system.


Which Material Certificate Records Does 21 CFR Part 11 Affect?

Not every certificate in your system is subject to Part 11 — only those that are:

  1. Required records under other FDA regulations — for example, material traceability records for equipment used in a facility operating under 21 CFR Part 211 (Current Good Manufacturing Practice for pharmaceuticals)

  2. Records incorporated into a customer's quality system — if your MTC or CoC will become part of a device history record (DHR), batch manufacturing record (BMR), or equipment qualification (IQ/OQ/PQ) package

  3. Electronically signed records in a regulated context — if a quality manager or authorized approver signs a certificate electronically and that signature is the document of record

Material certificates for standard structural or non-process-contacting applications in a pharma facility may not trigger Part 11. But for pressure-retaining components, product-contact surfaces, and equipment used in validated processes, the question must be addressed explicitly.


Core 21 CFR Part 11 Requirements for Certificate Management Systems

Electronic Records (§11.10)

Access controls (§11.10(d)): The system must limit access to authorized users only. For certificate management, this means role-based permissions — who can create, modify, approve, and view which certificate records — enforced at the application level, not relying on shared credentials.

Audit trail (§11.10(e)): The system must generate a computer-generated, date/time-stamped audit trail that records when entries are created, modified, or deleted. The original entry must be preserved. This requirement means that retroactively editing an approved certificate — changing a chemistry value, for example — is not permitted without creating a traceable record of the change.

Record integrity and legibility over the record lifetime (§11.10(b)): Records must be retrievable throughout the required retention period in a human-readable format. For pharmaceutical equipment with a product lifecycle of 20+ years, this means your system and storage format must remain accessible for the duration.

Operational system checks (§11.10(f)): The system must enforce sequencing — approval cannot precede receipt, a second-level approver cannot sign before a first-level review is complete.

Authority checks (§11.10(g)): Only authorized individuals can use the system functions available to their role. A junior inspector should not have the ability to perform a quality manager approval.

Electronic Signatures (§11.50, §11.100, §11.200)

If certificates are electronically signed:

  • Each electronic signature must be unique to one individual and not reused or reassigned
  • The signed record must display the full name of the signer, the date and time, and the meaning of the signature (e.g., "Approved by Quality Manager")
  • Signing must require two distinct identification components (typically username/password), or use a single biometric component
  • Electronic signatures must be linked to their respective records — they cannot be copied, extracted, and falsely applied to other records

Non-biometric electronic signatures (§11.200(a)): Must use at least two distinct identification components. A common implementation: the approver logs in once per session (authentication), and re-enters their password at the point of signing (re-authentication as a second component).


System Validation Requirements

21 CFR Part 11 is often paired with FDA guidance on computer system validation (CSV) under the GAMP framework. Your certificate management software must be validated to demonstrate it consistently performs its intended functions.

For a certificate management system, validation typically includes:

  • Installation Qualification (IQ) — the system is installed correctly and in a known configuration
  • Operational Qualification (OQ) — the system performs all required functions (approval workflow, audit trail, access control) correctly
  • Performance Qualification (PQ) — the system performs consistently under real-world operating conditions

A vendor-provided validation package does not eliminate your organization's validation responsibility, but it significantly reduces the effort. When evaluating certificate management software for a regulated environment, ask specifically for the validation documentation package (IQ/OQ/PQ templates, risk assessment, test scripts).


Practical Impact on Your Certificate Approval Workflow

For fabricators supplying into pharmaceutical manufacturing, Part 11 compliance changes the certificate approval workflow in several concrete ways:

Standard PracticePart 11 Requirement
Email sign-off ("looks good")Not compliant — no unique ID, no timestamp on record
Shared login for approvalsNot compliant — signatures must be unique to one individual
Overwriting a rejected certificateNot compliant — original record must be preserved
PDF in a shared driveMay be compliant if access controls and audit trail are documented
Paper signature with scanCompliant for paper records; if scanned, the scan must meet electronic record integrity requirements

What to Ask Your Certificate Management Software Vendor

  1. Does the system generate a computer-generated audit trail for every record creation, modification, and deletion?
  2. Are audit trail records protected from modification by users, including administrators?
  3. Does the electronic signature mechanism require two distinct identification components?
  4. Is the system validated, and is a validation package available?
  5. Does the system support role-based access with configurable authority levels?
  6. How does the system handle retention for records requiring 20+ year accessibility?

TestCert is designed with these requirements in mind — providing compliant electronic signatures, immutable audit trails, role-based access controls, and documentation to support validation activities in regulated environments.


Does 21 CFR Part 11 apply to all fabricators who sell to pharma companies?

Not automatically. Part 11 applies to records required by FDA regulations. If your certificates become part of a regulated record — incorporated into equipment qualification, batch records, or a Device History Record — then the applicable requirements flow through to your system. Your pharmaceutical customer's quality agreement will typically specify what compliance is expected of suppliers. Review those requirements carefully and maintain records demonstrating your system's compliance posture.

Is a PDF certificate signed with Adobe Acrobat sufficient for 21 CFR Part 11?

A PDF with an Adobe certificate-based digital signature can be compliant if the signature infrastructure meets Part 11 requirements for uniqueness, non-repudiation, and linkage to the record. However, the broader system requirements — audit trail for the entire certificate lifecycle, access controls, retention — must also be met by the surrounding workflow. A PDF signature alone, without a compliant records management system, is generally not sufficient.

What is the retention period for material certificates under FDA regulations?

There is no single FDA-mandated retention period for material certificates. Retention requirements derive from the specific regulation that requires the record. Under 21 CFR Part 211, batch records must be retained for at least one year after the expiration date of the drug batch, or one year after FDA approval of the batch. For equipment qualification records, many organizations apply the lifetime of the equipment plus a regulatory period. Consult your quality team and legal counsel for your specific situation.

Do Part 11 requirements apply to certificates received from suppliers, or only to our own records?

Part 11 applies to your organization's records system. When you receive a certificate from a supplier and incorporate it into your records — scanning, uploading, or referencing it in an approval workflow — the record in your system must comply with Part 11 if that record is subject to FDA oversight. The supplier's original issuance system is that supplier's compliance concern; your intake and storage system is yours.

What is the difference between 21 CFR Part 11 and EU GMP Annex 11?

Both regulate electronic records and signatures in pharmaceutical manufacturing, but they apply in different jurisdictions. 21 CFR Part 11 is the U.S. FDA regulation; EU GMP Annex 11 covers computerized systems used in GMP-regulated manufacturing in the European Union. They share many principles — audit trails, access controls, validation — but differ in specific technical requirements and enforcement approach. Organizations supplying into both markets need to address both frameworks.

Ready to automate your certificate workflow?

Try TestCert free

Related Guides

Related pages